Sunday, November 22, 2026
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News

No Systemic Immune Differences Found in Adolescent Gut-Brain Disorders

November 13, 2026
in Science News
Cassandra Pierce
By Cassandra Pierce Scienmag Editorial Profile - Systems Neuroscience
Reading Time: 5 mins read
0
No Systemic Immune Differences Found in Adolescent Gut-Brain Disorders

No Systemic Immune Differences Found in Adolescent Gut-Brain Disorders

65
SHARES
587
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

A cross-sectional case-control study conducted in Egypt has found no statistically significant differences in serum levels of CD163 or interleukin-17 A (IL-17 A) between adolescents diagnosed with functional gastrointestinal disorders and healthy peers. Published in the Bulletin of the National Research Centre, the research involved 181 adolescents aged 10 to 18 years, comprising 99 patients diagnosed with disorders of gut-brain interaction (DGBIs) according to Rome IV criteria and 82 healthy controls. The primary aim of the investigation was to evaluate whether systemic immune activation, as indicated by these specific circulating biomarkers, plays a measurable role in the pathophysiology of these chronic gastrointestinal conditions among teenagers.

Functional gastrointestinal disorders, now reclassified as disorders of gut-brain interaction, are characterized by persistent gastrointestinal symptoms in the absence of identifiable structural or biochemical abnormalities. These conditions are highly prevalent in the pediatric population, with epidemiological studies reporting a global prevalence ranging from 20 to 30% among children and adolescents. Despite their high frequency and significant impact on quality of life, school attendance, and psychosocial functioning, the underlying pathophysiology of these disorders remains incompletely understood. While they are generally considered non-inflammatory, emerging evidence has suggested the possibility of immune activation, particularly at the level of the intestinal mucosa, prompting researchers to investigate systemic markers of inflammation.

The study team selected soluble CD163 and IL-17 A as the primary biomarkers for analysis based on their distinct roles in the immune system. CD163 is the circulating form of the macrophage scavenger receptor and is widely recognized as a biomarker of macrophage activation and systemic inflammation. Elevated levels of soluble CD163 have been reported in various acute and chronic inflammatory and metabolic diseases. In the context of the gut, increased shedding of this receptor into the circulation reflects macrophage activation and ongoing inflammatory activity. By measuring CD163, the researchers aimed to assess the status of innate immunity in the study participants.

Interleukin-17 A, or IL-17 A, was selected as a marker of adaptive immunity. It is a pro-inflammatory cytokine produced by Th17 cells, which have a dual role in the intestine. During homeostasis, Th17 cells contribute to epithelial barrier maintenance, but when dysregulated, they drive mucosal inflammation. IL-17 A has been implicated in inflammatory bowel disease and other chronic gut disorders. The researchers hypothesized that these pathways might also be relevant to pediatric DGBIs, where neuroimmune activation and altered mucosal immunity have been proposed as key contributors to symptom generation. This study represents the first investigation of these two specific markers among adolescents with DGBIs according to Rome IV criteria.

The study was conducted at the National Research Centre in Egypt over a 16-month period, from March 2020 to June 2021. Participants were recruited from the outpatient clinics at the Medical Research Centre of Excellence and through school-based screening visits in four preparatory and secondary schools in Giza Governorate. The inclusion criteria required participants to be aged 10 to 18 years. For the case group, participants had to fulfill the Rome IV criteria for pediatric DGBIs. For the control group, participants had to be apparently healthy adolescents without chronic gastrointestinal symptoms. Exclusion criteria included the presence of organic gastrointestinal diseases such as inflammatory bowel disease or celiac disease, chronic systemic illnesses, acute infections at the time of assessment, and the use of immunosuppressive or anti-inflammatory medications.

All participants underwent a comprehensive clinical evaluation, including detailed history taking, anthropometric assessment, and laboratory investigations. Anthropometric measures included weight, height, and body mass index, which were assessed using calibrated equipment and interpreted according to World Health Organization standard deviation scores. Venous blood samples were collected from each participant for laboratory evaluation. Serum levels of CD163 and IL-17 A were measured once per participant using enzyme-linked immunosorbent assay (ELISA). This method involves the use of pre-coated microplates with specific capture antibodies, followed by the binding of the target analyte and the addition of a biotinylated detection antibody. The resulting color intensity was measured spectrophotometrically and was proportional to the analyte concentration.

The results indicated that DGBIs and FGIDs were significantly more prevalent among female participants than males, with a p-value of 0.023. This finding is consistent with previous research demonstrating a female predominance in adolescent DGBIs, which has been attributed to hormonal influences and psychosocial factors. Functional gastrointestinal symptoms, including irritable bowel syndrome and functional abdominal pain disorders, were significantly more common among patients with FGIDs compared to controls. However, the groups were comparable in age, anthropometric measures such as weight, height, and BMI, and hematologic indices including white blood cell and platelet counts. Hemoglobin levels were slightly but significantly lower in the FGID group, although the absolute difference was small and mean values in both groups remained within expected reference ranges for adolescents.

The primary outcome of the study focused on the comparison of serum CD163 and IL-17 A levels between the two groups. The analysis revealed no statistically significant differences in serum CD163 or IL-17 A levels between adolescents with DGBIs/FGIDs and healthy controls. Both p-values were greater than 0.5, indicating a lack of statistical significance. Effect sizes were calculated using rank-biserial correlation coefficients, which were close to zero for both markers, indicating minimal differences between the groups. The wide within-group variability observed for both biomarkers further supported the conclusion that any between-group differences were negligible in this study population.

The researchers noted several important limitations when interpreting these findings. First, the cross-sectional design relied on single-time-point serum measurements, which may not fully reflect the dynamic nature of immune responses or allow for the evaluation of temporal changes in immune marker concentrations. Second, although the final study sample exceeded the retrospectively estimated minimum sample size, the substantial inter-individual variability observed in serum CD163 and IL-17 A concentrations may have limited the statistical power to detect small between-group differences. Consequently, the absence of statistically significant differences should not be interpreted as evidence that immune mechanisms are absent in functional gastrointestinal disorders.

Furthermore, circulating serum biomarkers may not accurately reflect localized immune activity within the gastrointestinal mucosa. The absence of detectable differences in serum CD163 and IL-17 A suggests that any immune alterations in these adolescents may be confined to the gastrointestinal mucosa and are not necessarily accompanied by measurable systemic changes. Mucosal studies have previously demonstrated subtle histopathologic changes, including increased mast cells and eosinophils, in some patients with functional dyspepsia and irritable bowel syndrome, despite the absence of generalized systemic inflammation. Therefore, the negative findings in this study highlight the distinction between systemic and mucosal immune responses in DGBIs.

The study also excluded adolescents with clinically suspected post-infectious irritable bowel syndrome, defined as symptom onset clearly following documented acute infectious gastroenteritis. This exclusion means that the results may not be directly extrapolated to adolescents with post-infectious IBS phenotypes. Additionally, the recruitment of participants from both specialist outpatient clinics and school-based screening programs may have introduced selection bias and heterogeneity in disease severity. Adolescents presenting to tertiary clinics are more likely to have more persistent or severe symptoms, whereas school-recruited participants may include those with milder or previously unrecognized conditions. Such heterogeneity could have influenced the distribution of circulating biomarker concentrations and limited the generalizability of the findings.

In conclusion, the study found that DGBIs and FGIDs in Egyptian adolescents are characterized by significant clustering of symptom-based diagnostic features, with the absence of abnormalities in growth parameters, routine laboratory findings, and systemic inflammatory markers. The findings suggest an absence of detectable alterations in circulating CD163 and IL-17 A levels but do not exclude localized immune mechanisms or other pathophysiological pathways involved in disorders of gut-brain interaction. The researchers recommend that future studies use larger, multicenter cohorts and longitudinal designs with repeated measurements to better characterize temporal changes in immune activity. Incorporating mucosal immune profiling and detailed gut microbiome analysis is also suggested to elucidate the interaction between local inflammation, microbial dysbiosis, and symptom generation in pediatric FGIDs.

Subject of Research: Systemic CD163 and IL-17 A in functional gastrointestinal disorders: a case control study in Egyptian adolescents

Article Title: Systemic CD163 and IL-17 A in functional gastrointestinal disorders: a case control study in Egyptian adolescents

Article References: Abd El-Shaheed, A., Kamal, A. F., & Mahfouz, N. N. (2026). Systemic CD163 and IL-17 A in functional gastrointestinal disorders: a case control study in Egyptian adolescents. Bulletin of the National Research Centre, 50(1), Article 87. https://doi.org/10.1186/s42269-026-01473-0

Image Credits: AI Generated

DOI: 10.1186/s42269-026-01473-0

Keywords: Systemic, CD163, IL-17, functional, gastrointestinal, disorders, case, control, Egyptian, adolescents

Cite Scienmag News

Cassandra Pierce. (November 13, 2026). No Systemic Immune Differences Found in Adolescent Gut-Brain Disorders. Scienmag. https://scienmag.com/no-systemic-immune-differences-found-in-adolescent-gut-brain-disorders/

Cassandra Pierce. "No Systemic Immune Differences Found in Adolescent Gut-Brain Disorders." Scienmag, 13 November 2026, https://scienmag.com/no-systemic-immune-differences-found-in-adolescent-gut-brain-disorders/. Accessed 22 November 2026.

Cassandra Pierce. "No Systemic Immune Differences Found in Adolescent Gut-Brain Disorders." Scienmag. November 13, 2026. https://scienmag.com/no-systemic-immune-differences-found-in-adolescent-gut-brain-disorders/

Tags: adolescentscaseCD163ControldisordersEgyptianfunctionalgastrointestinalIL-17systemic
Share26Tweet16
Previous Post

Central Bargaining Outweighs Local Pressures in Reducing Chinese Workplace Accident Fatalities

Next Post

SGR5 loss disrupts Arabidopsis stem gravity response

Related Posts

Frost Damage to Leaves and Flowers Reshapes European Tree Reproductive Timing
Earth Science

Frost Damage to Leaves and Flowers Reshapes European Tree Reproductive Timing

November 22, 2026
Tailored Biomaterials Remodel Distinct Immune Barriers in Cold Digestive Cancers
Biotechnology

Tailored Biomaterials Remodel Distinct Immune Barriers in Cold Digestive Cancers

November 22, 2026
Infant Gut Metabolites Link Cesarean Delivery to Elevated Childhood Asthma Risk
Medicine

Infant Gut Metabolites Link Cesarean Delivery to Elevated Childhood Asthma Risk

November 22, 2026
Neural Network With Sliding Data Window Enhances Autonomous Ship Path Following
Technology and Engineering

Neural Network With Sliding Data Window Enhances Autonomous Ship Path Following

November 22, 2026
Review Identifies Key System Priorities for Decarbonizing Aluminum Building Windows
Earth Science

Review Identifies Key System Priorities for Decarbonizing Aluminum Building Windows

November 22, 2026
Review Shows Steel Slag Reuse Cuts Concrete Emissions and Captures Carbon
Earth Science

Review Shows Steel Slag Reuse Cuts Concrete Emissions and Captures Carbon

November 22, 2026
Next Post
SGR5 loss disrupts Arabidopsis stem gravity response

SGR5 loss disrupts Arabidopsis stem gravity response

  • Mothers who receive childcare support from maternal grandparents show more optimized

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27656 shares
    Share 11059 Tweet 6912
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    1061 shares
    Share 424 Tweet 265
  • Bee body mass, pathogens and local climate influence heat tolerance

    682 shares
    Share 273 Tweet 171
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    546 shares
    Share 218 Tweet 137
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    531 shares
    Share 212 Tweet 133
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Frost Damage to Leaves and Flowers Reshapes European Tree Reproductive Timing
  • Tailored Biomaterials Remodel Distinct Immune Barriers in Cold Digestive Cancers
  • Infant Gut Metabolites Link Cesarean Delivery to Elevated Childhood Asthma Risk
  • Neural Network With Sliding Data Window Enhances Autonomous Ship Path Following

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Biotechnology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Editorial Policy
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Science News
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,151 other subscribers

© 2026 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2026 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading